VIA · Via Transportation, Inc.

The thesis

Via Transportation's transit-software recovery has carried the shares to a $36.39 close on 28 October 2026, and the Q3 report on 9 November 2026 decides whether revenue and the promised Q4 profit justify the move. The company guided Q3 revenue to $137.6–138.2 million and positive adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) in Q4 when it reported on 6 August 2026.

The narrative is maturing: the story is well known among 14 covering brokerages, Oppenheimer raised its target again on 20 October 2026, and the shares have risen 78.9% over three months with a 14-day relative strength index (RSI) of 70.4 on 28 October 2026. The close sits just under the $37 targets of Oppenheimer and Citizens. It remains 32.5% below the 52-week high of $53.93 and below the $46.00 IPO price of September 2025. Company news after the 6 October 2026 report-date announcement is limited to analyst target changes.

Bullish and bearish views on Via Transportation, Inc.

The bull case on Via Transportation, Inc. (VIA), in brief: Guidance was raised after a beat. The bear case: Profit is still a promise.

Bull case

• Guidance was raised after a beat. Via reported Q2 revenue of $135.707 million against a $133.333 million analyst estimate on 6 August 2026 and lifted FY2026 revenue guidance to $550–553 million from $547–550 million (Benzinga). Q3 guidance of $137.6–138.2 million sat around the $137.942 million estimate.
• Analyst targets keep rising. Oppenheimer raised its target to $37 from $30 on 20 October 2026 and kept Outperform (fiscal.ai). Morgan Stanley went to $33 from $24 on 21 September 2026, and Citizens reiterated a $37 target on 18 September 2026.
• Broker support is broad. MarketBeat data reported by The Cerbat Gem on 27 September 2026 show 12 of 14 brokerages at Buy and a mean target of $38.70.
• The report date is fixed. Via announced on 6 October 2026 that Q3 results come before the US market opens on 9 November 2026, four days earlier than the 13 November 2026 date on some third-party calendars.

Bear case

• Profit is still a promise. Via's Q2 adjusted EBITDA loss was $3.4 million, and Q3 guidance is a $3.5–4.5 million adjusted EBITDA loss. Positive adjusted EBITDA first has to appear in Q4, which reports around February 2027.
• The price is near the top of published targets. The $36.39 close on 28 October 2026 is above the Morgan Stanley ($33) and Wells Fargo ($32) targets and $0.61 under the two $37 targets. Only the $38.70 mean target sits meaningfully higher.
• GAAP losses are large. The Q1 2026 GAAP net loss was $20.1 million, or $0.25 per share (Q1 10-Q). Adjusted EBITDA excludes items that GAAP counts.
• Legal overhang persists. Securities class actions over growth trajectory, annual recurring revenue (ARR) per customer and German land-and-expand are pending; the lead-plaintiff deadline was 10 August 2026.

Price setup

The shares closed at $36.39 on 28 October 2026, against $33.58 on 15 October 2026, $29.33 on 2 October 2026 and $27.98 on 18 September 2026 (adjusted daily closes). The RSI of 70.4 is above the 70 line that conventionally marks an overbought reading. Benzinga flagged the shares among overbought technology names on 24 September 2026.

The 50-day moving average was $24.91 on 27 September 2026 (The Cerbat Gem), so the price sits well above its recent average. Crowding evidence: 12 of 14 brokerages rate the shares Buy, the three-month gain is 78.9%, and an earnings report falls within 12 days. No resale registration statement or Form 144 filing by pre-IPO holders appears in recent filings.

Catalysts, next 30 days

• 9 November 2026: Q3 results before the US market opens, call at 8:30 a.m. Eastern. Revenue against $137.6–138.2 million, the Q4 adjusted EBITDA goal and gross margin against 39% in Q1 are the tests.
• ~9 November 2026, est.: Q3 Form 10-Q, which would show any legal accrual and the GAAP net loss.

What would change the view

The case breaks if Q3 revenue prints below the $137.6 million guidance floor, or if management withdraws or pushes out the positive Q4 adjusted EBITDA goal. A narrowing of the FY2026 revenue range with no raise from $550–553 million would weaken it. Price-wise, a weekly close below $29 would put the shares under the 2 October 2026 close of $29.33 and erase most of the October advance.

A Q3 print that raises FY2026 revenue guidance, holds gross margin at or above 39% and reaffirms Q4 profitability would strengthen it.

What it trades with

No current theme cluster carries Via, and the shares have traded on company-specific news since the 6 August 2026 report: guidance, analyst targets and the report date. The business depends on public-agency transit budgets, so municipal funding announcements bear on the 2027 contract pipeline of more than $700 million in growth annual contract value. No correlation figures against an index or peer group are available for this note.